Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

1,868.00p
   
  • Change Today:
    -30.00p
  • 52 Week High: 2,590.00
  • 52 Week Low: 1,637.00
  • Currency: UK Pounds
  • Shares Issued: 66.03m
  • Volume: 57,446
  • Market Cap: £1,233.49m
  • RiskGrade: 128

Genus sees 'good momentum' carry over into new trading year

By Iain Gilbert

Date: Wednesday 25 Nov 2020

LONDON (ShareCast) - (Sharecast News) - Animal genetics company Genus said on Wednesday that "good momentum" seen at the end of the previous trading year had carried over into the current one.
Genus stated that in the four months ended 31 October, its porcine and bovine businesses had seen further strong growth in volumes, revenues and adjusted operating profits, with royalty revenues in its porcine division also continuing to grow across Latin America, Europe and Asia.

The FTSE 250-listed firm said trading was ahead of expectations, with adjusted pre-tax tax profits showing strong growth year-on-year, while net debt at the end of the period was also lower than expected.

Research and development costs were lower due to some collaboration activity with external research institutions being delayed due to the Covid-19 pandemic and associated lockdowns.

Looking forward, Genus expects there will continue to be "some challenges" stemming from the pandemic, with currency headwinds anticipated.

However, although Genus said it was difficult to predict, based on the first four months' trading momentum, the group currently anticipates that it will continue to make "strategic and financial progress" and was likely to perform ahead of previous profit growth expectations for the current trading year.

As of 0840 GMT, Genus shares were up 4.08% at 4,080.0p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Genus Market Data

Currency UK Pounds
Share Price 1,868.00p
Change Today -30.00p
% Change -1.58 %
52 Week High 2,590.00
52 Week Low 1,637.00
Volume 57,446
Shares Issued 66.03m
Market Cap £1,233.49m
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
96.04% below the market average96.04% below the market average96.04% below the market average96.04% below the market average96.04% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
53.64% below the market average53.64% below the market average53.64% below the market average53.64% below the market average53.64% below the market average
18.52% above the sector average18.52% above the sector average18.52% above the sector average18.52% above the sector average18.52% above the sector average
Income
86.4% below the market average86.4% below the market average86.4% below the market average86.4% below the market average86.4% below the market average
71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average
Growth
67.9% below the market average67.9% below the market average67.9% below the market average67.9% below the market average67.9% below the market average
64.71% below the sector average64.71% below the sector average64.71% below the sector average64.71% below the sector average64.71% below the sector average

What The Brokers Say

Strong Buy 5
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 7
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Interim Final
Ex-Div 29-Feb-24 09-Nov-23
Paid 28-Mar-24 08-Dec-23
Amount 10.30p 21.70p

Trades for 13-May-2024

Time Volume / Share Price
16:11 2 @ 1,866.00p
16:35 34,896 @ 1,868.00p
16:35 2 @ 1,868.00p
16:35 181 @ 1,868.00p
16:35 90 @ 1,868.00p

Genus Key Personnel

CFO Alison Henriksen
CEO Jorgen Kokke

Top of Page